1. Generics Bulletin
  2. >>Partnered Content

Achieving Firsts In Biosimilars From China

 
• By Andrew Warmington

Explore this insightful article and exclusive video with Henlius’ COO to discover:

  • Its achievements in biosimilar approvals, including serplulimab, and its anticipated launch into the European market.
  • The essential role of strategic partnerships in Henlius’ success, including over 20 global collaborations with Abbott Laboratories, Accord Healthcare, Eurofarma and more.
  • An overview of Henlius’ late-stage pipeline drugs, and ambitious plans shaping the future of biosimilars.

Click here to download this Special Report in PDF format


More from Partnered Content

Sponsored by:

Building a Stronger Pharma Industry for Patients and Providers

Learn more about the challenges faced by today’s drug developers and the critical factors to consider as sponsors navigate the supply chain, keep up with regulatory requirements, and ensure patient access. Discover more about the role of generics and how Aspire Pharma can help.

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Achieving Firsts In Biosimilars From China

Discover Henlius’ groundbreaking achievements, and their mission to deliver affordable, innovative drugs worldwide through strategic partnerships.

More from Products

Sponsored by:

A Crossroads for Global Health: Strengthening the Future of Vaccines

Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies

Sponsored by:

A Crossroads for Global Health: Strengthening the Future of Vaccines

Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies

Sponsored by:

Podcast Series: Navigating Regulatory Changes & Market Dynamics: CRO Perspectives on the Future of Clinical Trials

Insights from Novotech on Evolving Trends Impacting Global Clinical Development

Sponsored by:

Meeting the demands of the global biologics market

Lonza is addressing the growing global demand for biologics by utilizing its expert teams and the advanced capabilities of its newly acquired large-scale manufacturing site in Vacaville, California. Joanna McCafferty, Director of Commercial Development, shares more in this brief video. Ask ChatG